SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $457,346 | +0.6% | 98,354 | 0.0% | 0.02% | +5.9% |
Q1 2023 | $454,395 | -61.9% | 98,354 | -33.3% | 0.02% | -62.2% |
Q4 2022 | $1,192,050 | +31.0% | 147,531 | -10.0% | 0.04% | +21.6% |
Q3 2022 | $910,000 | +6.6% | 163,924 | 0.0% | 0.04% | +8.8% |
Q2 2022 | $854,000 | -36.6% | 163,924 | 0.0% | 0.03% | -27.7% |
Q1 2022 | $1,347,000 | -72.4% | 163,924 | -50.0% | 0.05% | -70.1% |
Q4 2021 | $4,878,000 | -35.5% | 327,850 | -18.1% | 0.16% | -35.4% |
Q3 2021 | $7,559,000 | +1.6% | 400,147 | 0.0% | 0.24% | +0.4% |
Q2 2021 | $7,439,000 | -43.0% | 400,147 | -30.3% | 0.24% | -46.1% |
Q1 2021 | $13,060,000 | -14.4% | 573,823 | -18.3% | 0.45% | -16.2% |
Q4 2020 | $15,252,000 | +136.6% | 702,523 | +9.6% | 0.54% | +121.5% |
Q3 2020 | $6,445,000 | +29.5% | 641,268 | 0.0% | 0.24% | +28.0% |
Q2 2020 | $4,976,000 | -23.9% | 641,268 | 0.0% | 0.19% | -36.1% |
Q1 2020 | $6,541,000 | -7.3% | 641,268 | 0.0% | 0.30% | +10.9% |
Q4 2019 | $7,054,000 | +21.0% | 641,268 | 0.0% | 0.27% | +5.1% |
Q3 2019 | $5,829,000 | -20.1% | 641,268 | 0.0% | 0.25% | -14.8% |
Q2 2019 | $7,298,000 | -0.1% | 641,268 | 0.0% | 0.30% | +0.3% |
Q1 2019 | $7,304,000 | +252.2% | 641,268 | +178.9% | 0.30% | +233.7% |
Q4 2018 | $2,074,000 | -44.7% | 229,900 | -8.0% | 0.09% | -34.6% |
Q3 2018 | $3,750,000 | – | 250,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |